Wachtell Guides Bausch & Lomb In $2.5B Novartis Deal
Bausch & Lomb, led by Wachtell Lipton Rosen & Katz, has agreed to buy a suite of treatments from Novartis that treat dry eyes and eye pain in a transaction valued...To view the full article, register now.
Already a subscriber? Click here to view full article